Bluejay Diagnostics, Inc., headquartered in Acton, MA, trades on Nasdaq and is seeking FDA approval for product submissions.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bluejay Diagnostics, Inc., headquartered in Acton, MA, trades on Nasdaq and is seeking FDA approval for product submissions.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
Acton
town in Massachusetts, United States
Nothing else this week.
Related events
- Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- uniQure N.V. traded on the Nasdaq stock exchange and submitted a Biologics License Application (BLA) for accelerated approval of its gene therapy.
- Cardiol Therapeutics Inc. is listed on Nasdaq and is developing therapy for an FDA-approved indication.
- Calithera Biosciences, headquartered in South San Francisco, is listed on the NASDAQ stock exchange.